Log in

Zynex Stock Price, News & Analysis (OTCMKTS:ZYXI)

$11.69
+0.55 (+4.94 %)
(As of 10/14/2019 03:56 AM ET)
Today's Range
$10.85
Now: $11.69
$11.84
50-Day Range
$8.47
MA: $9.80
$12.51
52-Week Range
$2.58
Now: $11.69
$13.10
Volume444,677 shs
Average Volume210,801 shs
Market Capitalization$379.43 million
P/E Ratio53.14
Dividend YieldN/A
Beta1.05
Zynex, Inc, a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ZYXI
CUSIPN/A
Phone303-703-4906

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$23.43 million
Cash Flow$0.65 per share
Book Value$0.15 per share

Profitability

Net Income$7.36 million

Miscellaneous

EmployeesN/A
Market Cap$379.43 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ZYXI News and Ratings via Email

Sign-up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.


Zynex (OTCMKTS:ZYXI) Frequently Asked Questions

What is Zynex's stock symbol?

Zynex trades on the OTCMKTS under the ticker symbol "ZYXI."

How were Zynex's earnings last quarter?

Zynex Inc. (OTCMKTS:ZYXI) issued its quarterly earnings results on Wednesday, July, 31st. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.06. The firm earned $10.30 million during the quarter, compared to analyst estimates of $9.84 million. Zynex had a return on equity of 152.81% and a net margin of 33.33%. View Zynex's Earnings History.

What guidance has Zynex issued on next quarter's earnings?

Zynex updated its third quarter 2019 earnings guidance on Wednesday, July, 31st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $10.7-11.2 million, compared to the consensus revenue estimate of $10.3 million.

What price target have analysts set for ZYXI?

2 brokers have issued 1 year price objectives for Zynex's shares. Their predictions range from $10.75 to $12.00. On average, they anticipate Zynex's stock price to reach $11.38 in the next twelve months. This suggests that the stock has a possible downside of 2.7%. View Analyst Price Targets for Zynex.

What is the consensus analysts' recommendation for Zynex?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zynex.

Has Zynex been receiving favorable news coverage?

Media coverage about ZYXI stock has trended negative this week, InfoTrie reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Zynex earned a media sentiment score of -2.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Zynex.

Who are some of Zynex's key competitors?

What other stocks do shareholders of Zynex own?

Who are Zynex's key executives?

Zynex's management team includes the folowing people:
  • Mr. Thomas Sandgaard, Founder, Pres, CEO & Chairman (Age 60)
  • Mr. Daniel J. Moorhead, Chief Financial Officer (Age 47)
  • Mr. David B. Mogill, VP of Operations
  • Mr. Robert Bird, VP of Marketing
  • Mr. Steve Siefring, Director of Bus. Devel.

How do I buy shares of Zynex?

Shares of ZYXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Zynex's stock price today?

One share of ZYXI stock can currently be purchased for approximately $11.69.

How big of a company is Zynex?

Zynex has a market capitalization of $379.43 million and generates $23.43 million in revenue each year. The company earns $7.36 million in net income (profit) each year or $0.22 on an earnings per share basis. View Additional Information About Zynex.

What is Zynex's official website?

The official website for Zynex is http://www.zynexmed.com/.

How can I contact Zynex?

Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The company can be reached via phone at 303-703-4906 or via email at [email protected]


MarketBeat Community Rating for Zynex (OTCMKTS ZYXI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  140 (Thanks for Voting!)
Underperform Votes:  130 (Thanks for Voting!)
Total Votes:  270
MarketBeat's community ratings are surveys of what our community members think about Zynex and other stocks. Vote "Outperform" if you believe ZYXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZYXI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Featured Article: What is the Rule of 72?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel